Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.76
+0.03 (0.39%)
At close: Oct 24, 2025, 4:00 PM EDT
7.91
+0.15 (1.93%)
After-hours: Oct 24, 2025, 7:58 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $458.42 million as of October 24, 2025. Its market cap has decreased by -48.82% in one year.
Market Cap
458.42M
Enterprise Value
194.45M
1-Year Change
-48.82%
Ranking
Category
Stock Price
$7.76
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $458.42M, a decrease of -44.73%. That is a compound annual growth rate of -11.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 458.42M | -35.36% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |